Drugs Market Growth is Driven by Rising Consumer Awareness, Growth of Lifestyle Diseases, and Expanding Distribution Channels Drive Market Growth; U.S. and Asia-Pacific Regions See Notable ...

GSK (NYSE:GSK) announced Tuesday that Arexvy, a Phase 3 trial for its FDA-approved vaccine against Respiratory Syncytial ...

The global dysmenorrhea treatment market, valued at approximately USD 5,937.8 million in 2022, is projected to reach USD 6,324.5 million in 2023 and USD 13,106.5 million by 2032, exhibiting a CAGR of ...

Further dampening sentiment on Monday was an order from a U.S. judge for market heavyweight Alphabet's Google to overhaul its ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

On Friday, federal health officials announced a significant initiative to bolster the United States' preparedness against potential bird flu outbreak ...

Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...

US has announced team up with multinational pharmaceutical companies CSL, GSK, Sanofi, and Seqirus for a $72 million worth of ...

GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...

There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...